Saturday, June 13, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1032 of 1,261

  1. US 7544670

    HoxD3, HoxA3 and HoxB3 compositions and methods for improved wound healing

    The Regents of the University of California · Granted Jun 9, 2009 · Expires Jun 4, 2029

    granted

  2. US 7544778

    Recombinant antigens for diagnosis and prevention of murine typhus

    United States of America as represented by the Secretary of the Air Force · Granted Jun 9, 2009 · Expires Jun 4, 2029

    granted

  3. US 7544486

    Nell peptide expression systems and bone formation activity of nell peptide

    The Regents of the University of California · Granted Jun 9, 2009 · Expires Jun 4, 2029

    granted

  4. EP 2064340

    VERFAHREN ZUR BEWERTUNG VON PATIENTEN BEI DER BEHANDLUNG MIT AUF RET-REZEPTOR-TYROSINKINASE ABZIELENDEN ARZNEISTOFFEN

    ASTRAZENECA AB [SE] · Granted Jun 3, 2009 · Expires May 29, 2029

    granted

  5. US 7541034

    Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 2, 2009 · Expires May 28, 2029

    granted

  6. US 7541478

    Coumarin derivative and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jun 2, 2009 · Expires May 28, 2029

    granted

  7. US 7541429

    Comparative ligand mapping from MHC positive cells

    The Board of Regents of the University of Oklahoma · Granted Jun 2, 2009 · Expires May 28, 2029

    granted

  8. US 7541463

    Sulfur-containing naphthalimide derivatives

    East China University of Science and Technology · Granted Jun 2, 2009 · Expires May 28, 2029

    granted

  9. US 7541331

    Surfactant treatment regimen

    Discovery Laboratories, Inc. · Granted Jun 2, 2009 · Expires May 28, 2029

    granted

  10. US 7541139

    Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 2, 2009 · Expires May 28, 2029

    granted

  11. US 7541043

    Vaccine for protection against Shigella sonnei disease

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 2, 2009 · Expires May 28, 2029

    granted

  12. US 7541035

    Immunogenic peptides for the treatment of prostate and breast cancer

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 2, 2009 · Expires May 28, 2029

    granted

  13. US 7541040

    Chimeric molecule for the treatment of th2-like cytokine mediated disorders

    The United States of America as represented by the Department of Health and Human Serivces · Granted Jun 2, 2009 · Expires May 28, 2029

    granted

  14. US 7541346

    Pancratistatin cyclic phosphate prodrugs and phenpanstatin cyclic phosphate prodrugs

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jun 2, 2009 · Expires May 28, 2029

    granted

  15. US 7541381

    Non-covalent inhibitors of AmpC β-lactamase

    Northwestern University · Granted Jun 2, 2009 · Expires May 28, 2029

    granted

  16. AU 2008328307

    5-[(3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino]-1h-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents

    ASTRAZENECA AB [SE] · Granted May 28, 2009 · Expires May 23, 2029

    granted

  17. AR 065277

    COMBINACIONES DE BENZOTIAZOLONA AGONISTA 2-BETA-ADRENOCEPTOR

    ASTRAZENECA AB [SE] · Granted May 27, 2009 · Expires May 22, 2029

    granted

  18. EP 2061775

    SPIRO-OXAZOLIDINON-VERBINDUNGEN UND IHRE VERWENDUNG ALS VERSTÄRKER METABOTROPER GLUTAMATREZEPTOREN

    ASTRAZENECA AB [SE] · Granted May 27, 2009 · Expires May 22, 2029

    granted

  19. AR 065278

    SALES DE DERIVADO DE BENZOTIAZOL

    ASTRAZENECA AB [SE] · Granted May 27, 2009 · Expires May 22, 2029

    granted

  20. US 7538183

    HPV vaccine comprising peptides from host cell proteins

    University College Cardiff Consultants Limited · Granted May 26, 2009 · Expires May 21, 2029

    granted

  21. US 7538129

    Diazonamide A analog

    The Board of Regents of the University of Texas System · Granted May 26, 2009 · Expires May 21, 2029

    granted

  22. US 7538189

    Methods of making deuterated cyclosporin analogs

    Isotechnika, Inc. · Granted May 26, 2009 · Expires May 21, 2029

    granted

  23. US 7538136

    Crystalline forms of atorvastatin

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 26, 2009 · Expires May 21, 2029

    granted

  24. US 7537765

    Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein

    The United States of America, as represented by the Department of Health and Human Services · Granted May 26, 2009 · Expires May 21, 2029

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.